“Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?”, Reumatismo, vol. 66, no. 4, pp. 285–303, Mar. 2015, doi: 10.4081/reumatismo.2014.799.